Acorn Bioventures, L.P.

Insider Reports History

Location
295 Madison Avenue, 32 Nd Fl, New York, NY
Signature
ACORN BIOVENTURES, L.P., By: Acorn Capital Advisors GP, LLC, its general partner, By: /s/ Anders Hove, Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Acorn Bioventures, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Reneo Pharmaceuticals, Inc. 10%+ Owner Class A Common Stock 1.44M $3.85M $2.67 Oct 4, 2024 Direct
OnKure Therapeutics, Inc. 10%+ Owner Common Stock 1.71M $3.16M $1.85 May 15, 2025 Direct
OnKure Therapeutics, Inc. 10%+ Owner Common Stock 1.13M $2.09M $1.85 May 15, 2025 By Acorn Bioventures 2, L.P.

Insider Reports Filed by Acorn Bioventures, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OKUR OnKure Therapeutics, Inc. May 15, 2025 2 $2.59M 4 May 19, 2025 10%+ Owner
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 0 $0 3 Oct 9, 2024 10%+ Owner